Cytogenetics in solid tumors: lessons from the Philadelphia Chromosome.

  • Sudoyo A
  • Hardi F
  • 10


    Mendeley users who have this article in their library.
  • 4


    Citations of this article.


Although presently known as an environmentally-related disease and appears mostly sporadic, cancer is regarded as a genetic disease based on the presence of gene mutation as a consistent factor. The "Philadelphia Chromosome" found consistently among chronic myeloid leukemia (CML) patients was the first significant finding of a chromosomal abnormality specifically related to a particular disease. Starting from this point, cytogenetics as the study of chromosomes has become a valuable tool in the assessment of cancer - as an aid in diagnosis, thus guiding therapy, and as a prognostic marker. As is the nature of the proliferating marrow, chromosomal abnormalities were found mostly in hematologic malignancies, and the findings more pathognomonic. The situation is different in solid tumors, which when visible to the naked eye already will have complex chromosomal changes and thus pose technical difficulties to the cytogeneticist. However, scientists believe that the shift in chromosomal studies from conventional cytogenetics to molecular cytogenetics will provide further information regarding solid tumors.

Author-supplied keywords

  • cytogenetics
  • solid tumors

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

  • PUI: 361998954
  • PMID: 21339549
  • ISSN: 0125-9326
  • SCOPUS: 2-s2.0-79959521152
  • SGR: 79959521152


  • Aru W Sudoyo

  • Fransiska Hardi

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free